| 1 |
Dexamethasone FDA Label
|
| 2 |
Hepatitis B therapy. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):275-84.
|
| 3 |
ClinicalTrials.gov (NCT04689152) A Multicenter, Randomized, Open-label Phase III Clinical Trial to Evaluate Efficacy and Safety of the Cellgram-LC in Patients With Alcoholic Liver Cirrhosis. U.S.National Institutes of Health.
|
| 4 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 5 |
Interference in clinical laboratory tests, with special regard to the bilirubin assay: effects of a metabolite of the new prolyl 4-hydroxylase inhibitor, Lufironil. Eur J Clin Chem Clin Biochem. 1994Jul;32(7):515-20.
|
| 6 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027533)
|
| 7 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 8 |
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.Gastroenterology. 2019 Nov;157(5):1383-1397.e11. doi: 10.1053/j.gastro.2019.07.028. Epub 2019 Jul 22.
|
| 9 |
Early growth response-1 transcription factor promotes hepatic fibrosis and steatosis in long-term ethanol-fed Long-Evans rats.Liver Int. 2012 May;32(5):761-70. doi: 10.1111/j.1478-3231.2012.02752.x. Epub 2012 Jan 31.
|
| 10 |
Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays.Oncol Rep. 2013 Nov;30(5):2476-80. doi: 10.3892/or.2013.2674. Epub 2013 Aug 20.
|
| 11 |
High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma.BMC Cancer. 2018 May 25;18(1):597. doi: 10.1186/s12885-018-4503-6.
|
| 12 |
Expression and prognostic significance of insulinlike growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.Oncol Rep. 2019 Apr;41(4):2299-2310. doi: 10.3892/or.2019.6995. Epub 2019 Feb 1.
|
| 13 |
Hepatic clearance of tissue-type plasminogen activator and plasma kallikrein in experimental liver fibrosis.Liver Int. 2003 Dec;23(6):476-83. doi: 10.1111/j.1478-3231.2003.00872.x.
|
| 14 |
Insights into hepatic and renal FXR/DDAH-1/eNOS pathway and its role in the potential benefit of rosuvastatin and silymarin in hepatic nephropathy.Exp Mol Pathol. 2018 Dec;105(3):293-310. doi: 10.1016/j.yexmp.2018.10.004. Epub 2018 Oct 9.
|
| 15 |
Pro-fibrogenic potential of PDGF-D in liver fibrosis.J Hepatol. 2007 Jun;46(6):1064-74. doi: 10.1016/j.jhep.2007.01.029. Epub 2007 Feb 23.
|
| 16 |
An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats.Hepatology. 2008 Dec;48(6):1913-23. doi: 10.1002/hep.22533.
|
| 17 |
Liver stiffness correlates with serum osteopontin and TAZ expression in human liver cirrhosis.Ann N Y Acad Sci. 2020 Apr;1465(1):117-131. doi: 10.1111/nyas.14259. Epub 2019 Nov 7.
|
| 18 |
CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.J Pathol. 2018 Jul;245(3):297-310. doi: 10.1002/path.5083. Epub 2018 May 9.
|
| 19 |
TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.Br J Biomed Sci. 2019 Jan;76(1):35-41. doi: 10.1080/09674845.2018.1547179. Epub 2018 Dec 3.
|
| 20 |
VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.BMC Cancer. 2018 May 2;18(1):511. doi: 10.1186/s12885-018-4435-1.
|
| 21 |
Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.Clin Chim Acta. 2013 Jun 5;421:121-5. doi: 10.1016/j.cca.2013.03.004. Epub 2013 Mar 13.
|
| 22 |
Aquaporin-1 associated with hepatic arterial capillary proliferation on hepatic sinusoid in human cirrhotic liver.Liver Int. 2011 Nov;31(10):1554-64. doi: 10.1111/j.1478-3231.2011.02610.x. Epub 2011 Jul 29.
|
| 23 |
Adenoviralbone morphogenetic protein? and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model.Mol Med Rep. 2017 Dec;16(6):9431-9440. doi: 10.3892/mmr.2017.7785. Epub 2017 Oct 12.
|
| 24 |
Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study.Gene. 2019 Mar 10;688:107-118. doi: 10.1016/j.gene.2018.11.082. Epub 2018 Dec 5.
|
| 25 |
Correlation between hepatic oxidative damage and clinical severity and mitochondrial gene sequencing results in biliary atresia.Hepatol Res. 2019 Jun;49(6):695-704. doi: 10.1111/hepr.13324. Epub 2019 Apr 1.
|
| 26 |
Influence of CYP2D6 and 2-adrenergic receptor gene polymorphisms on the hemodynamic response to propranolol in Chinese Han patients with cirrhosis.J Gastroenterol Hepatol. 2016 Apr;31(4):829-34. doi: 10.1111/jgh.13198.
|
| 27 |
Roles of Endothelin B Receptors and Endothelial Nitric Oxide Synthase in the Regulation of Pulmonary Hemodynamic in Cirrhotic Rats.J Cardiovasc Pharmacol. 2019 Mar;73(3):178-185. doi: 10.1097/FJC.0000000000000650.
|
| 28 |
Circulating Resistin Is Associated with Plasma Glucagon-Like Peptide-1 in Cirrhotic Patients with Hepatitis C Virus Genotype-4 Infection.Endocr Res. 2020 Feb;45(1):17-23. doi: 10.1080/07435800.2019.1627551. Epub 2019 Jun 10.
|
| 29 |
KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.PLoS One. 2017 Nov 17;12(11):e0188307. doi: 10.1371/journal.pone.0188307. eCollection 2017.
|
| 30 |
Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I.Int J Biochem Cell Biol. 2002 Mar;34(3):242-52. doi: 10.1016/s1357-2725(01)00123-6.
|
| 31 |
Development of A New Mouse Model for Intrahepatic Cholangiocellular Carcinoma: Accelerating Functions of Pecam-1.Cancers (Basel). 2019 Jul 24;11(8):1045. doi: 10.3390/cancers11081045.
|
| 32 |
Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis.Biomed Res Int. 2018 Dec 12;2018:4706976. doi: 10.1155/2018/4706976. eCollection 2018.
|
| 33 |
A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis.Hepatology. 2009 Oct;50(4):1184-93. doi: 10.1002/hep.23137.
|
| 34 |
Adenoviral delivery of truncated MMP-8 fused with the hepatocyte growth factor mutant 1K1 ameliorates liver cirrhosis and promotes hepatocyte proliferation.Drug Des Devel Ther. 2015 Oct 16;9:5655-67. doi: 10.2147/DDDT.S92481. eCollection 2015.
|
| 35 |
L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle.Can J Gastroenterol Hepatol. 2019 Apr 28;2019:8182195. doi: 10.1155/2019/8182195. eCollection 2019.
|
| 36 |
Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: Effect on conventional coagulation tests and thrombomodulin-modified thrombin generation.J Hepatol. 2020 Jan;72(1):85-94. doi: 10.1016/j.jhep.2019.09.008. Epub 2019 Sep 16.
|
| 37 |
Analysis of Lamin B1, Vimentin and Anti-Ku86 as Prospective Biomarkers of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection.Cell Physiol Biochem. 2019;52(3):595-605. doi: 10.33594/000000042.
|
| 38 |
ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma.World J Gastrointest Oncol. 2019 May 15;11(5):424-435. doi: 10.4251/wjgo.v11.i5.424.
|
| 39 |
Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2006 Nov;291(5):G877-84. doi: 10.1152/ajpgi.00537.2005. Epub 2006 Jun 15.
|
| 40 |
2adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease: Liver cirrhosis and osteoarthritis.Mol Med Rep. 2018 Jun;17(6):7987-7995. doi: 10.3892/mmr.2018.8820. Epub 2018 Mar 29.
|
| 41 |
Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.Hepatology. 2009 Dec;50(6):1924-35. doi: 10.1002/hep.23222.
|
| 42 |
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis.J Antimicrob Chemother. 2017 Mar 1;72(3):812-815. doi: 10.1093/jac/dkw492.
|
| 43 |
Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion.BMC Nephrol. 2018 Sep 19;19(1):238. doi: 10.1186/s12882-018-1039-6.
|
| 44 |
The clinical significance of intrahepatic Th22 cells in liver cirrhosis.Adv Clin Exp Med. 2019 Jun;28(6):765-770. doi: 10.17219/acem/94062.
|
| 45 |
Characterization of chemically induced liver injuries using gene co-expression modules.PLoS One. 2014 Sep 16;9(9):e107230. doi: 10.1371/journal.pone.0107230. eCollection 2014.
|
| 46 |
Efficacy of Albumin Treatment for Patients with CirrhosisandInfections Unrelated to Spontaneous BacterialPeritonitis.Clin Gastroenterol Hepatol. 2020 Apr;18(4):963-973.e14. doi: 10.1016/j.cgh.2019.07.055. Epub 2019 Aug 5.
|
| 47 |
Effects of "Essential AD2" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) Deficiency.Am J Ther. 2019 Sep/Oct;26(5):583-588. doi: 10.1097/MJT.0000000000000744.
|
| 48 |
Impact of large volume paracentesis on respiratory parameters including transpulmonary pressure and on transpulmonary thermodilution derived hemodynamics: A prospective study.PLoS One. 2018 Mar 14;13(3):e0193654. doi: 10.1371/journal.pone.0193654. eCollection 2018.
|
| 49 |
Increased Circulating VAP-1 Levels Are Associated with Liver Fibrosis in Chronic Hepatitis C Infection.J Clin Med. 2019 Jan 17;8(1):103. doi: 10.3390/jcm8010103.
|
| 50 |
Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes.Horm Metab Res. 2007 Nov;39(11):781-9. doi: 10.1055/s-2007-992129.
|
| 51 |
Prevalence of beta2-glycoprotein I antibody in patients with liver cirrhosis: relationship with beta2-glycoprotein I plasma levels and thrombosis.Clin Appl Thromb Hemost. 2004 Apr;10(2):183-6. doi: 10.1177/107602960401000210.
|
| 52 |
Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis.Toxicol Sci. 2016 Jan;149(1):67-88. doi: 10.1093/toxsci/kfv214. Epub 2015 Sep 22.
|
| 53 |
Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension.Liver Int. 2015 Apr;35(4):1393-402. doi: 10.1111/liv.12613. Epub 2014 Jul 5.
|
| 54 |
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in theBDL rat model.J Mol Med (Berl). 2019 Mar;97(3):423-434. doi: 10.1007/s00109-019-01746-4. Epub 2019 Feb 5.
|
| 55 |
Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.J Cell Mol Med. 2015 Apr;19(4):806-14. doi: 10.1111/jcmm.12497. Epub 2015 Feb 20.
|
| 56 |
Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1.Oncotarget. 2018 Feb 19;9(44):27321-27332. doi: 10.18632/oncotarget.24535. eCollection 2018 Jun 8.
|
| 57 |
Activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in sera of patients with hepatitis C.Arch Med Sci. 2018 Mar;14(2):281-287. doi: 10.5114/aoms.2016.60406. Epub 2016 Jun 7.
|
| 58 |
Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis.J Transl Med. 2012 May 24;10:106. doi: 10.1186/1479-5876-10-106.
|
| 59 |
Expression and clinical significance of livin protein in hepatocellular carcinoma.Dis Markers. 2013;35(5):489-96. doi: 10.1155/2013/781740. Epub 2013 Oct 3.
|
| 60 |
Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.J Cancer Res Clin Oncol. 2020 Jan;146(1):87-96. doi: 10.1007/s00432-019-03090-z. Epub 2019 Nov 22.
|
| 61 |
Systemic inhibition of BMP1-3 decreases progression of CCl(4)-induced liver fibrosis in rats.Growth Factors. 2017 Dec;35(6):201-215. doi: 10.1080/08977194.2018.1428966. Epub 2018 Feb 27.
|
| 62 |
Increased bactericidal/permeability increasing protein in patients with cirrhosis.Liver Int. 2010 Jan;30(1):94-101. doi: 10.1111/j.1478-3231.2009.02121.x. Epub 2009 Sep 18.
|
| 63 |
A critical role of hepatitis B virus polymerase in cirrhosis, hepatocellular carcinoma, and steatosis.FEBS Open Bio. 2017 Dec 19;8(1):130-145. doi: 10.1002/2211-5463.12357. eCollection 2018 Jan.
|
| 64 |
Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.Eur J Clin Microbiol Infect Dis. 2011 Jun;30(6):761-6. doi: 10.1007/s10096-010-1149-y. Epub 2011 Jan 13.
|
| 65 |
High-fat diet-induced plasma protein and liver changes in obese rats can be attenuated by melatonin supplementation.Nutr Res. 2017 Jun;42:51-63. doi: 10.1016/j.nutres.2017.04.011. Epub 2017 May 5.
|
| 66 |
Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury.J Pharmacol Exp Ther. 2010 Jun;333(3):639-49. doi: 10.1124/jpet.109.165118. Epub 2010 Mar 2.
|
| 67 |
Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Mol Med. 2011;17(11-12):1285-94. doi: 10.2119/molmed.2011.00149. Epub 2011 Aug 19.
|
| 68 |
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.Cancer Genet Cytogenet. 2006 Nov;171(1):31-8. doi: 10.1016/j.cancergencyto.2006.06.014.
|
| 69 |
Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis.Ann Surg Oncol. 2010 Dec;17(12):3386-93. doi: 10.1245/s10434-010-1197-7. Epub 2010 Jun 30.
|
| 70 |
Surgery for Infective Endocarditis: Outcomes and Predictors of Mortality in 360 Consecutive Patients.Med Sci Monit. 2017 Jul 25;23:3617-3626. doi: 10.12659/msm.902340.
|
| 71 |
Association of serum levels of C-reactive protein with CRP-717 T/C polymorphism and viremia in HCV and HBV carriers.Rev Soc Bras Med Trop. 2019 Feb 21;52:e20180455. doi: 10.1590/0037-8682-0455-2018.
|
| 72 |
IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir.Mol Cells. 2017 Jun 30;40(6):418-425. doi: 10.14348/molcells.2017.0051. Epub 2017 Jun 14.
|
| 73 |
Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection.Cytokine. 2019 May;117:72-78. doi: 10.1016/j.cyto.2019.02.006. Epub 2019 Feb 28.
|
| 74 |
The impact of serotonergic system dysfunction on the regulation of P4501A isoforms during liver insufficiency and consequences for thyroid hormone homeostasis.Food Chem Toxicol. 2016 Nov;97:70-81. doi: 10.1016/j.fct.2016.08.027. Epub 2016 Aug 24.
|
| 75 |
Interaction of heterogeneous nuclear ribonucleoprotein A1 with cytochrome P450 2A6 mRNA: implications for post-transcriptional regulation of the CYP2A6 gene.Mol Pharmacol. 2004 Jun;65(6):1405-14. doi: 10.1124/mol.65.6.1405.
|
| 76 |
Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Patients With Liver Cirrhosis.J Pharm Sci. 2019 Dec;108(12):3923-3931. doi: 10.1016/j.xphs.2019.09.019. Epub 2019 Sep 25.
|
| 77 |
The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients.Cancer Gene Ther. 2020 Jun;27(6):486-497. doi: 10.1038/s41417-019-0123-9. Epub 2019 Jul 18.
|
| 78 |
Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.Can J Physiol Pharmacol. 2010 Jun;88(6):636-43. doi: 10.1139/Y10-038.
|
| 79 |
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.Clin Transplant. 2016 Apr;30(4):452-60. doi: 10.1111/ctr.12710. Epub 2016 Mar 1.
|
| 80 |
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.J Clin Gastroenterol. 2007 Jul;41(6):616-23. doi: 10.1097/01.mcg.0000225642.90898.0e.
|
| 81 |
The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis.Am J Pathol. 2010 Dec;177(6):2837-49. doi: 10.2353/ajpath.2010.100425. Epub 2010 Oct 29.
|
| 82 |
Non-neoplastic Portal Vein Thrombosis in HCV Cirrhosis Patients: Is it an Immuno-Inflammatory Disorder?.Ann Hepatol. 2017 Jul-Aug;16(4):574-583. doi: 10.5604/01.3001.0010.0296.
|
| 83 |
Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies.J Thromb Haemost. 2008 Aug;6(8):1336-43. doi: 10.1111/j.1538-7836.2008.03015.x. Epub 2008 May 14.
|
| 84 |
Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.J Thromb Haemost. 2018 Jun;16(6):1132-1140. doi: 10.1111/jth.14011. Epub 2018 May 17.
|
| 85 |
Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.Gastroenterology. 2010 Nov;139(5):1567-76, 1576.e1-6. doi: 10.1053/j.gastro.2010.07.057. Epub 2010 Aug 11.
|
| 86 |
Relationships between serum selenium and zinc concentrations versus profibrotic and proangiogenic cytokines (FGF-19 and endoglin) in patients with alcoholic liver cirrhosis.Ann Agric Environ Med. 2017 Sep 21;24(3):544-548. doi: 10.26444/aaem/76937. Epub 2017 Sep 16.
|
| 87 |
Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.Liver Transpl. 2018 May;24(5):595-605. doi: 10.1002/lt.25041. Epub 2018 Apr 6.
|
| 88 |
Suppression of MicroRNA-219-5p Activates Keratinocyte Growth Factor to Mitigate Severity of Experimental Cirrhosis.Cell Physiol Biochem. 2016;40(1-2):253-262. doi: 10.1159/000452542. Epub 2016 Nov 18.
|
| 89 |
Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.Oncogene. 2014 Sep 25;33(39):4786-94. doi: 10.1038/onc.2013.424. Epub 2013 Oct 21.
|
| 90 |
Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.Liver Int. 2007 Sep;27(7):960-8. doi: 10.1111/j.1478-3231.2007.01542.x.
|
| 91 |
Hexokinase isoenzymes in normal and cirrhotic human liver: suppression of glucokinase in cirrhosis.Biochim Biophys Acta. 1998 Jan 8;1379(1):134-42. doi: 10.1016/s0304-4165(97)00092-5.
|
| 92 |
Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population.PLoS One. 2015 Nov 23;10(11):e0143069. doi: 10.1371/journal.pone.0143069. eCollection 2015.
|
| 93 |
The role of incretin hormones and glucagon in patients with liver disease.Dan Med J. 2017 May;64(5):B5363.
|
| 94 |
Utility of glutamine synthetase immunohistochemistry in identifying features of regressed cirrhosis.Mod Pathol. 2020 Mar;33(3):448-455. doi: 10.1038/s41379-019-0346-1. Epub 2019 Aug 7.
|
| 95 |
Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma.Liver Int. 2006 May;26(4):424-32. doi: 10.1111/j.1478-3231.2006.01242.x.
|
| 96 |
Preclinical hypogonadism in genetic hemochromatosis in the early stage of the disease: evidence of hypothalamic dysfunction.J Endocrinol Invest. 1992 Jun;15(6):423-8. doi: 10.1007/BF03348765.
|
| 97 |
Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis.Clin Appl Thromb Hemost. 2018 Mar;24(2):254-262. doi: 10.1177/1076029617725600. Epub 2017 Oct 19.
|
| 98 |
Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.Ann Hepatol. 2019 Jan-Feb;18(1):58-67. doi: 10.5604/01.3001.0012.7863.
|
| 99 |
Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells.J Hepatol. 2003 Nov;39(5):779-85. doi: 10.1016/s0168-8278(03)00361-1.
|
| 100 |
Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.Hepatology. 2020 Jan;71(1):306-333. doi: 10.1002/hep.30866.
|
| 101 |
Sex differences in NMDA receptor expression in human alcoholics.Alcohol Alcohol. 2009 Nov-Dec;44(6):594-601. doi: 10.1093/alcalc/agp052. Epub 2009 Sep 7.
|
| 102 |
Distribution of Glutathione S-Transferase Omega Gene Polymorphism with Different Stages of HBV Infection Including Hepatocellular Carcinoma in the Egyptian Population.Asian Pac J Cancer Prev. 2016;17(4):2145-50. doi: 10.7314/apjcp.2016.17.4.2145.
|
| 103 |
Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis.Onco Targets Ther. 2018 Sep 12;11:5789-5796. doi: 10.2147/OTT.S168444. eCollection 2018.
|
| 104 |
Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.Mol Med. 2018 Mar 15;24(1):5. doi: 10.1186/s10020-018-0008-7.
|
| 105 |
Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis.Toxicol Appl Pharmacol. 2016 Sep 1;306:58-68. doi: 10.1016/j.taap.2016.07.003. Epub 2016 Jul 7.
|
| 106 |
The association of complex liver disorders with HBV genotypes prevalent in Pakistan.Virol J. 2007 Nov 27;4:128. doi: 10.1186/1743-422X-4-128.
|
| 107 |
Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study.Infect Genet Evol. 2019 Jan;67:112-120. doi: 10.1016/j.meegid.2018.10.008. Epub 2018 Oct 15.
|
| 108 |
Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.Biochem Biophys Res Commun. 2001 Nov 23;289(1):205-11. doi: 10.1006/bbrc.2001.5916.
|
| 109 |
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.J Gastroenterol Hepatol. 2019 May;34(5):937-946. doi: 10.1111/jgh.14454. Epub 2018 Sep 26.
|
| 110 |
Erythrocyte porphobilinogen deaminase activity and primary liver cancer.J Intern Med. 1995 Mar;237(3):309-13. doi: 10.1111/j.1365-2796.1995.tb01180.x.
|
| 111 |
HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma.Cancers (Basel). 2019 Nov 26;11(12):1876. doi: 10.3390/cancers11121876.
|
| 112 |
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.Lancet. 1992 Oct 3;340(8823):813-7. doi: 10.1016/0140-6736(92)92685-9.
|
| 113 |
Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.Curr Opin Nephrol Hypertens. 2004 Jul;13(4):451-8. doi: 10.1097/01.mnh.0000133976.32559.b0.
|
| 114 |
Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma.Oncotarget. 2017 Jun 20;8(25):40019-40036. doi: 10.18632/oncotarget.16685.
|
| 115 |
Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro.Int Immunopharmacol. 2017 Feb;43:227-235. doi: 10.1016/j.intimp.2016.12.023. Epub 2016 Dec 30.
|
| 116 |
Peripheral type I interferon receptor correlated with oxidative stress in chronic hepatitis B virus infection.J Interferon Cytokine Res. 2013 Aug;33(8):405-14. doi: 10.1089/jir.2012.0153. Epub 2013 May 10.
|
| 117 |
Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C.Ann Hepatol. 2018 July - August ,;17(4):569-576. doi: 10.5604/01.3001.0012.0918.
|
| 118 |
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.Aliment Pharmacol Ther. 2019 Nov;50(10):1112-1119. doi: 10.1111/apt.15515. Epub 2019 Oct 3.
|
| 119 |
N-glycopeptide Signatures of IgA(2) in Serum from Patients with Hepatitis B Virus-related Liver Diseases.Mol Cell Proteomics. 2019 Nov;18(11):2262-2272. doi: 10.1074/mcp.RA119.001722. Epub 2019 Sep 9.
|
| 120 |
Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.Liver Int. 2018 Jan;38(1):50-58. doi: 10.1111/liv.13485. Epub 2017 Jun 20.
|
| 121 |
Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients.Dis Markers. 2017;2017:2176460. doi: 10.1155/2017/2176460. Epub 2017 Jun 8.
|
| 122 |
Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.Transpl Int. 2017 Feb;30(2):196-208. doi: 10.1111/tri.12896. Epub 2017 Jan 20.
|
| 123 |
Expression of LAIR-1 (CD305) on Human Blood Monocytes as a Marker of Hepatic Cirrhosis Progression.J Immunol Res. 2019 Mar 24;2019:2974753. doi: 10.1155/2019/2974753. eCollection 2019.
|
| 124 |
Dietary -Lactalbumin protects against thioacetamide-induced liver cirrhosis by maintaining gut-liver axis function in rats.Biosci Biotechnol Biochem. 2020 Jan;84(1):171-177. doi: 10.1080/09168451.2019.1660613. Epub 2019 Sep 2.
|
| 125 |
Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis.Sci Rep. 2018 Sep 14;8(1):14065. doi: 10.1038/s41598-018-32482-3.
|
| 126 |
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study.Hepatology. 2019 Jul;70(1):319-333. doi: 10.1002/hep.30592. Epub 2019 Apr 25.
|
| 127 |
Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?.Ann Hepatol. 2019 Jan-Feb;18(1):78-88. doi: 10.5604/01.3001.0012.7865.
|
| 128 |
Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-B/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.Hepatology. 2020 Apr;71(4):1262-1278. doi: 10.1002/hep.30917. Epub 2020 Jan 26.
|
| 129 |
Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.Int J Oncol. 2005 Mar;26(3):661-71.
|
| 130 |
Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma.Gastroenterology. 2003 Apr;124(4):940-8. doi: 10.1053/gast.2003.50151.
|
| 131 |
Serum CA125 levels are decreased in rectal cancer but increased in fibrosis-associated diseases and in most types of cancers.Prog Mol Biol Transl Sci. 2019;162:241-252. doi: 10.1016/bs.pmbts.2018.12.012. Epub 2019 Mar 6.
|
| 132 |
Platelet count increases after viral elimination in chronic HCV, independent of the presence or absence of cirrhosis.Liver Int. 2019 Nov;39(11):2061-2065. doi: 10.1111/liv.14203. Epub 2019 Aug 21.
|
| 133 |
How to estimate renal function in patients with liver disease: choosing the most suitable equation.Int Urol Nephrol. 2019 Apr;51(4):677-690. doi: 10.1007/s11255-019-02110-8. Epub 2019 Mar 4.
|
| 134 |
Curcumin and /-Adrenergic Antagonists Cotreatment Reverse Liver Cirrhosis in Hamsters: Participation of Nrf-2 and NF-B.J Immunol Res. 2019 Apr 30;2019:3019794. doi: 10.1155/2019/3019794. eCollection 2019.
|
| 135 |
Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated Cirrhosis.Clin Transl Gastroenterol. 2019 Jan;10(1):e00002. doi: 10.14309/ctg.0000000000000002.
|
| 136 |
Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.Liver Int. 2004 Aug;24(4):345-53. doi: 10.1111/j.1478-3231.2004.0933.x.
|
| 137 |
Xiaochaihutang attenuates liver fibrosis by activation of Nrf2 pathway in rats.Biomed Pharmacother. 2017 Dec;96:847-853. doi: 10.1016/j.biopha.2017.10.065. Epub 2017 Nov 6.
|
| 138 |
The selective mineralocorticoid receptor antagonist eplerenone prevents decompensation of the liver in cirrhosis.Br J Pharmacol. 2018 Jul;175(14):2956-2967. doi: 10.1111/bph.14341. Epub 2018 Jun 7.
|
| 139 |
NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.Int J Cancer. 2019 Aug 1;145(3):662-670. doi: 10.1002/ijc.32134. Epub 2019 Feb 4.
|
| 140 |
Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation.Mol Pathol. 2001 Aug;54(4):270-4. doi: 10.1136/mp.54.4.270.
|
| 141 |
Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease.PLoS One. 2014 Apr 17;9(4):e95604. doi: 10.1371/journal.pone.0095604. eCollection 2014.
|
| 142 |
Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.Environ Health Prev Med. 2012 Nov;17(6):444-56. doi: 10.1007/s12199-012-0273-y. Epub 2012 Mar 11.
|
| 143 |
AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle.Nat Commun. 2018 Feb 7;9(1):540. doi: 10.1038/s41467-018-03060-y.
|
| 144 |
Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.Mol Genet Metab. 2014 Mar;111(3):309-313. doi: 10.1016/j.ymgme.2013.12.008. Epub 2013 Dec 19.
|
| 145 |
Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.Asian Pac J Cancer Prev. 2016;17(4):2019-25. doi: 10.7314/apjcp.2016.17.4.2019.
|
| 146 |
Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.Lipids Health Dis. 2017 Jan 11;16(1):5. doi: 10.1186/s12944-016-0400-7.
|
| 147 |
Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma.Cancer Biol Ther. 2016;17(2):151-62. doi: 10.1080/15384047.2015.1121345. Epub 2015 Nov 30.
|
| 148 |
Expression and distribution of prolactin receptor in normal, fibrotic, and cirrhotic human liver.Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):584-9. doi: 10.1055/s-2006-948310.
|
| 149 |
Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.J Gastroenterol Hepatol. 2017 Apr;32(4):916-924. doi: 10.1111/jgh.13493.
|
| 150 |
Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.Cell Death Dis. 2015 May 7;6(5):e1751. doi: 10.1038/cddis.2015.120.
|
| 151 |
1,8-Cineole Ameliorates Steatosis of Pten Liver Specific KO Mice via Akt Inactivation.Int J Mol Sci. 2015 May 27;16(6):12051-63. doi: 10.3390/ijms160612051.
|
| 152 |
Pleiotrophin inhibits transforming growth factor beta1-induced apoptosis in hepatoma cell lines.Mol Carcinog. 2008 Oct;47(10):784-96. doi: 10.1002/mc.20438.
|
| 153 |
Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease.Liver Int. 2020 Jan;40(1):18-31. doi: 10.1111/liv.14272. Epub 2019 Nov 4.
|
| 154 |
PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.J Gastrointestin Liver Dis. 2017 Mar;26(1):37-43. doi: 10.15403/jgld.2014.1121.261.pnp.
|
| 155 |
Nogo-C contributes to HCC tumorigenesis via suppressing cell growth and its interactome analysis with comparative proteomics research.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2044-55. eCollection 2014.
|
| 156 |
Serum Amyloid A-Positive Hepatocellular Neoplasm: A New Type of Tumor Arising in Patients with Advanced Alcoholic Disease.Dig Dis. 2015 Sep;33(5):648-54. doi: 10.1159/000438474. Epub 2015 Sep 23.
|
| 157 |
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease.Dig Liver Dis. 2009 Mar;41(3):212-6. doi: 10.1016/j.dld.2008.06.001. Epub 2008 Jul 25.
|
| 158 |
The Best Anticoagulation Strategy for Cirrhotic Patients who Underwent Splenectomy: A Network Meta-Analysis.Gastroenterol Res Pract. 2017;2017:9216172. doi: 10.1155/2017/9216172. Epub 2017 Jun 6.
|
| 159 |
Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.J Proteomics. 2018 Oct 30;189:67-74. doi: 10.1016/j.jprot.2018.02.003. Epub 2018 Feb 7.
|
| 160 |
Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.Toxicol Appl Pharmacol. 2014 Jan 15;274(2):328-38. doi: 10.1016/j.taap.2013.11.017. Epub 2013 Dec 7.
|
| 161 |
NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases.Int J Infect Dis. 2019 Mar;80:147-152. doi: 10.1016/j.ijid.2019.01.038. Epub 2019 Jan 24.
|
| 162 |
Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model.Blood Transfus. 2019 May;17(3):237-246. doi: 10.2450/2018.0105-18. Epub 2018 Nov 9.
|
| 163 |
Inhibition of arsenic-induced rat liver injury by grape seed exact through suppression of NADPH oxidase and TGF-/Smad activation.Toxicol Appl Pharmacol. 2011 Aug 1;254(3):323-31. doi: 10.1016/j.taap.2011.04.022. Epub 2011 May 13.
|
| 164 |
Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.BMC Cancer. 2019 Apr 27;19(1):395. doi: 10.1186/s12885-019-5603-7.
|
| 165 |
Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.Int J Oncol. 2006 May;28(5):1081-8.
|
| 166 |
Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice.PLoS One. 2013;8(2):e54962. doi: 10.1371/journal.pone.0054962. Epub 2013 Feb 11.
|
| 167 |
Differential expression of sprouty genes in hepatocellular carcinoma.J Surg Oncol. 2012 Mar;105(3):273-6. doi: 10.1002/jso.22095. Epub 2011 Sep 19.
|
| 168 |
Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease.Dig Liver Dis. 2019 Jul;51(7):1001-1007. doi: 10.1016/j.dld.2018.12.005. Epub 2018 Dec 19.
|
| 169 |
Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression.Sci Rep. 2018 Jul 23;8(1):11033. doi: 10.1038/s41598-018-29349-y.
|
| 170 |
Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease.J Hepatol. 2004 Nov;41(5):744-50. doi: 10.1016/j.jhep.2003.06.003.
|
| 171 |
STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.Hepatology. 2006 Dec;44(6):1441-51. doi: 10.1002/hep.21419.
|
| 172 |
Association of TAP1 and TAP2 polymorphisms with the outcome of persistent HBV infection in a northeast Han Chinese population.Scand J Gastroenterol. 2012 Nov;47(11):1368-74. doi: 10.3109/00365521.2012.725090. Epub 2012 Sep 19.
|
| 173 |
Hepatocyte-specific expression of constitutively active Alk5 exacerbates thioacetamide-induced liver injury in mice.Heliyon. 2017 May 19;3(5):e00305. doi: 10.1016/j.heliyon.2017.e00305. eCollection 2017 May.
|
| 174 |
A new data analysis method based on feature linear combination.J Biomed Inform. 2019 Jun;94:103173. doi: 10.1016/j.jbi.2019.103173. Epub 2019 Apr 6.
|
| 175 |
Association of mRNA expression of toll-like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis, and hepatocellular carcinoma.J Med Virol. 2017 Jun;89(6):1008-1014. doi: 10.1002/jmv.24719. Epub 2017 Jan 10.
|
| 176 |
Review of Defective NADPH Oxidase Activity and Myeloperoxidase Release in Neutrophils From Patients With Cirrhosis.Front Immunol. 2019 May 8;10:1044. doi: 10.3389/fimmu.2019.01044. eCollection 2019.
|
| 177 |
TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis.Int J Mol Sci. 2019 Mar 14;20(6):1277. doi: 10.3390/ijms20061277.
|
| 178 |
Role of deleterious single nucleotide variants in the coding regions of TNFAIP3 for Japanese autoimmune hepatitis with cirrhosis.Sci Rep. 2019 May 28;9(1):7925. doi: 10.1038/s41598-019-44524-5.
|
| 179 |
Elevated endotoxin levels in non-alcoholic fatty liver disease.J Inflamm (Lond). 2010 Mar 30;7:15. doi: 10.1186/1476-9255-7-15.
|
| 180 |
Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia.J Gastroenterol Hepatol. 2018 Feb 10:10.1111/jgh.14123. doi: 10.1111/jgh.14123. Online ahead of print.
|
| 181 |
A candidate gene study for the association of host single nucleotide polymorphisms with liver cirrhosis risk in chinese hepatitis B patients.Genet Test Mol Biomarkers. 2013 Sep;17(9):681-6. doi: 10.1089/gtmb.2013.0058. Epub 2013 Jul 11.
|
| 182 |
TGF-1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-1/Smad pathway.Toxicol Appl Pharmacol. 2014 Oct 15;280(2):335-44. doi: 10.1016/j.taap.2014.08.006. Epub 2014 Aug 19.
|
| 183 |
Clinical significance of transient receptor potential vanilloid 2 expression in human hepatocellular carcinoma.Cancer Genet Cytogenet. 2010 Feb;197(1):54-9. doi: 10.1016/j.cancergencyto.2009.08.007.
|
| 184 |
Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl(4)-induced cirrhotic rats.Front Med. 2019 Jun;13(3):398-408. doi: 10.1007/s11684-019-0689-5. Epub 2019 Jun 11.
|
| 185 |
Clinical significance of endothelial progenitor cells in patients with liver cirrhosis with or without hepatocellular carcinoma.Eur J Gastroenterol Hepatol. 2020 Jan;32(1):87-94. doi: 10.1097/MEG.0000000000001484.
|
| 186 |
Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis.Am J Gastroenterol. 2002 Jun;97(6):1489-95. doi: 10.1111/j.1572-0241.2002.05794.x.
|
| 187 |
Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.Eur J Gastroenterol Hepatol. 2019 Aug;31(8):1040-1048. doi: 10.1097/MEG.0000000000001380.
|
| 188 |
Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818794190.
|
| 189 |
mRNA detection of tumor-rejection genes BAGE, GAGE, and MAGE in peritoneal fluid from patients with ovarian carcinoma as a potential diagnostic tool.Cancer. 2002 Jun 25;96(3):187-93. doi: 10.1002/cncr.10622.
|
| 190 |
Prevalence of hepatitis C virus genotypes in southern Italy.Eur J Epidemiol. 1997 Jan;13(1):49-54. doi: 10.1023/a:1007324300358.
|
| 191 |
Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations.Curr Drug Targets. 2017;18(7):786-793. doi: 10.2174/1389450116666150804105937.
|
| 192 |
Expression and prognostic significance of doublecortin-like kinase 1 in patients with hepatocellular carcinoma.Oncol Lett. 2017 Dec;14(6):7529-7537. doi: 10.3892/ol.2017.7082. Epub 2017 Sep 27.
|
| 193 |
Systems analysis of key genes and pathways in the progression of hepatocellular carcinoma.Medicine (Baltimore). 2018 Jun;97(23):e10892. doi: 10.1097/MD.0000000000010892.
|
| 194 |
A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cells.J Biol Chem. 2010 Feb 19;285(8):5428-37. doi: 10.1074/jbc.M109.035295. Epub 2009 Dec 17.
|
| 195 |
Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.PLoS One. 2015 Apr 10;10(4):e0122961. doi: 10.1371/journal.pone.0122961. eCollection 2015.
|
| 196 |
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.PLoS One. 2017 Feb 23;12(2):e0171260. doi: 10.1371/journal.pone.0171260. eCollection 2017.
|
| 197 |
5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis.Liver Int. 2013 Apr;33(4):535-43. doi: 10.1111/liv.12110. Epub 2013 Jan 31.
|
| 198 |
A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.Liver Int. 2014 Apr;34(4):558-66. doi: 10.1111/liv.12330. Epub 2013 Oct 16.
|
| 199 |
Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers.J Gastroenterol. 2010 Mar;45(3):317-25. doi: 10.1007/s00535-009-0152-5. Epub 2009 Nov 12.
|
| 200 |
Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.Sci Rep. 2019 Oct 31;9(1):15788. doi: 10.1038/s41598-019-52356-6.
|
| 201 |
Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population.Oncotarget. 2016 Nov 22;7(47):77968-77977. doi: 10.18632/oncotarget.12864.
|
| 202 |
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice.Mol Genet Metab. 2017 Apr;120(4):299-305. doi: 10.1016/j.ymgme.2017.02.011. Epub 2017 Mar 2.
|
| 203 |
Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.World J Gastroenterol. 2018 Oct 14;24(38):4356-4368. doi: 10.3748/wjg.v24.i38.4356.
|
| 204 |
Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor -dependent macrophage differentiation.J Biol Chem. 2017 Apr 28;292(17):6882-6894. doi: 10.1074/jbc.M117.778761. Epub 2017 Mar 22.
|
| 205 |
P-Selectin Level at First and Third Day After Portal Hypertensive Splenectomy for Early Prediction of Portal Vein Thrombosis in Patients With Cirrhosis.Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):76S-83S. doi: 10.1177/1076029618788180. Epub 2018 Jul 22.
|
| 206 |
The NRF2PGC? pathway activates kynurenine aminotransferase 4 via attenuation of an E3 ubiquitin ligase, synoviolin, in a cecal ligation/perforationinduced septic mouse model.Mol Med Rep. 2018 Aug;18(2):2467-2475. doi: 10.3892/mmr.2018.9175. Epub 2018 Jun 15.
|
| 207 |
Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.Gastroenterology. 2011 Jan;140(1):344-55. doi: 10.1053/j.gastro.2010.07.049. Epub 2010 Aug 2.
|
| 208 |
PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.PLoS One. 2013 Oct 14;8(10):e75982. doi: 10.1371/journal.pone.0075982. eCollection 2013.
|
| 209 |
SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C.Gut. 2004 Mar;53(3):446-50. doi: 10.1136/gut.2003.028274.
|
| 210 |
Differential pattern of pre-S mutations/deletions and its association with hepatitis B virus genotypes in Eastern India.Infect Genet Evol. 2012 Mar;12(2):384-91. doi: 10.1016/j.meegid.2012.01.007. Epub 2012 Jan 16.
|
| 211 |
Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.J Gastroenterol. 2020 Feb;55(2):227-243. doi: 10.1007/s00535-019-01633-2. Epub 2019 Oct 10.
|
| 212 |
Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. Mov Disord. 2012 Sep 1;27(10):1317-22. doi: 10.1002/mds.25138. Epub 2012 Aug 23.
|
| 213 |
Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.J Pathol. 2019 Jun;248(2):164-178. doi: 10.1002/path.5243. Epub 2019 Mar 8.
|
| 214 |
Mechanism and significance of changes in glutamate-cysteine ligase expression during hepatic fibrogenesis.J Biol Chem. 2012 Oct 19;287(43):36341-55. doi: 10.1074/jbc.M112.370775. Epub 2012 Aug 31.
|
| 215 |
Blood ethanol levels of nonabstinent Japanese alcoholic men in the morning after drinking and their ADH1B and ALDH2 genotypes.Alcohol Alcohol. 2014 Jan-Feb;49(1):31-7. doi: 10.1093/alcalc/agt136. Epub 2013 Aug 21.
|
| 216 |
Further clarification of the contribution of the ADH1C gene to vulnerability of alcoholism and selected liver diseases.Hum Genet. 2012 Aug;131(8):1361-74. doi: 10.1007/s00439-012-1163-5. Epub 2012 Apr 5.
|
| 217 |
Women and alcohol susceptibility: could differences in alcohol metabolism predispose women to alcohol-related diseases?.Arch Womens Ment Health. 2003 Nov;6(4):231-8. doi: 10.1007/s00737-003-0015-7.
|
| 218 |
Serum AKR1B10 predicts the risk of hepatocellular carcinoma - A retrospective single-center study.Gastroenterol Hepatol. 2019 Dec;42(10):614-621. doi: 10.1016/j.gastrohep.2019.06.007. Epub 2019 Sep 5.
|
| 219 |
Genetic Polymorphisms of Cytochrome P4501A1 (CYP1A1) and Glutathione S-Transferase P1 (GSTP1) and Risk of Hepatocellular Carcinoma Among Chronic Hepatitis C Patients in Egypt.Biochem Genet. 2016 Oct;54(5):696-713. doi: 10.1007/s10528-016-9749-6. Epub 2016 Jun 7.
|
| 220 |
Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis.Arch Toxicol. 2014 Apr;88(4):997-1006. doi: 10.1007/s00204-013-1191-5. Epub 2014 Jan 1.
|
| 221 |
Expression of P450 and nuclear receptors in normal and end-stage Chinese livers.World J Gastroenterol. 2014 Jul 14;20(26):8681-90. doi: 10.3748/wjg.v20.i26.8681.
|
| 222 |
Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.Nephrol Dial Transplant. 2018 Aug 1;33(8):1333-1343. doi: 10.1093/ndt/gfx354.
|
| 223 |
Validation study associating glutaminase promoter variations with hepatic encephalopathy in East Asian populations.J Gastroenterol Hepatol. 2017 Apr;32(4):901-907. doi: 10.1111/jgh.13618.
|
| 224 |
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.J Hepatol. 2000 Dec;33(6):907-14. doi: 10.1016/s0168-8278(00)80122-1.
|
| 225 |
Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.PLoS One. 2018 Aug 20;13(8):e0202686. doi: 10.1371/journal.pone.0202686. eCollection 2018.
|
| 226 |
Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.Cytotherapy. 2017 Sep;19(9):1113-1124. doi: 10.1016/j.jcyt.2017.05.009. Epub 2017 Jun 30.
|
| 227 |
Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.Oncogene. 2017 Dec 14;36(50):6895-6905. doi: 10.1038/onc.2017.291. Epub 2017 Aug 28.
|
| 228 |
NUDT15 Polymorphism Confer Increased Susceptibility to Thiopurine-Induced Leukopenia in Patients With Autoimmune Hepatitis and Related Cirrhosis.Front Pharmacol. 2019 Apr 9;10:346. doi: 10.3389/fphar.2019.00346. eCollection 2019.
|
| 229 |
Genetic Risk Factors for Autoimmune Thyroid Disease might Affect the Susceptibility to and Modulate the Progression of Primary Biliary Cholangitis.J Gastrointestin Liver Dis. 2017 Sep;26(3):245-252. doi: 10.15403/jgld.2014.1121.263.kus.
|
| 230 |
UDP-glucuronosyltransferase 1A7 polymorphisms are associated with liver cirrhosis.Biochem Biophys Res Commun. 2008 Feb 15;366(3):643-8. doi: 10.1016/j.bbrc.2007.11.125. Epub 2007 Dec 3.
|
| 231 |
Increased SSeCKS expression in rat hepatic stellate cells upon activation in vitro and in vivo.Inflammation. 2013 Dec;36(6):1415-23. doi: 10.1007/s10753-013-9681-4.
|
| 232 |
Identification of the inhibitory activity of walnut extract on the E3 ligase Syvn1.Mol Med Rep. 2018 Dec;18(6):5701-5708. doi: 10.3892/mmr.2018.9576. Epub 2018 Oct 23.
|
| 233 |
The Role of Dermcidin in the Diagnosis and Staging of Hepatocellular Carcinoma.Genet Test Mol Biomarkers. 2018 Apr;22(4):218-223. doi: 10.1089/gtmb.2017.0230. Epub 2018 Mar 16.
|
| 234 |
The endoplasmic reticulum co-chaperone ERdj3/DNAJB11 promotes hepatocellular carcinoma progression through suppressing AATZ degradation.Future Oncol. 2018 Dec;14(29):3001-3013. doi: 10.2217/fon-2018-0401. Epub 2018 Jul 11.
|
| 235 |
Diagnostic value of serum cytokeratin-18 in children with chronic liver disease.J Paediatr Child Health. 2020 Jan;56(1):41-46. doi: 10.1111/jpc.14488. Epub 2019 May 4.
|
| 236 |
Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation.Transplant Proc. 2011 Dec;43(10):3973-9. doi: 10.1016/j.transproceed.2011.08.113.
|
| 237 |
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.Liver Int. 2018 Aug;38(8):1475-1486. doi: 10.1111/liv.13696. Epub 2018 Feb 10.
|
| 238 |
HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.Cell Death Dis. 2018 May 1;9(5):513. doi: 10.1038/s41419-018-0534-9.
|
| 239 |
Hepatoprotective effects and mechanisms of dehydrocavidine in rats with carbon tetrachloride-induced hepatic fibrosis.J Ethnopharmacol. 2011 Oct 31;138(1):76-84. doi: 10.1016/j.jep.2011.08.039. Epub 2011 Aug 24.
|
| 240 |
Selenium and selenoprotein P in nonalcoholic fatty liver disease.Hormones (Athens). 2020 Mar;19(1):61-72. doi: 10.1007/s42000-019-00127-3. Epub 2019 Sep 6.
|
| 241 |
Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11). J Med Genet. 2009 Oct;46(10):663-70. doi: 10.1136/jmg.2009.066613. Epub 2009 Jun 8.
|
| 242 |
Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.Hepatol Res. 2018 Feb;48(3):E311-E319. doi: 10.1111/hepr.12988. Epub 2017 Nov 3.
|
| 243 |
Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.Dis Markers. 2019 Oct 22;2019:8964015. doi: 10.1155/2019/8964015. eCollection 2019.
|
| 244 |
miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients.Biochem Biophys Res Commun. 2012 Apr 27;421(1):4-8. doi: 10.1016/j.bbrc.2012.03.025. Epub 2012 Mar 13.
|
| 245 |
Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1.Am J Pathol. 2017 Jan;187(1):33-41. doi: 10.1016/j.ajpath.2016.09.013. Epub 2016 Nov 14.
|
| 246 |
Augmenter of liver regeneration protects against carbon tetrachloride-induced liver injury by promoting autophagy in mice.Oncotarget. 2017 Feb 21;8(8):12637-12648. doi: 10.18632/oncotarget.14478.
|
| 247 |
Dysregulation of FTX/miR-545 signaling pathway downregulates Tim-3 and is responsible for the abnormal activation of macrophage in cirrhosis.J Cell Biochem. 2019 Feb;120(2):2336-2346. doi: 10.1002/jcb.27562. Epub 2018 Oct 10.
|
| 248 |
Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.Pathol Oncol Res. 2017 Jan;23(1):33-39. doi: 10.1007/s12253-016-0079-0. Epub 2016 Jun 8.
|
| 249 |
PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition.Oncotarget. 2017 Mar 22;8(35):58184-58198. doi: 10.18632/oncotarget.16436. eCollection 2017 Aug 29.
|
| 250 |
Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics.Oncotarget. 2017 Jun 28;8(37):62011-62028. doi: 10.18632/oncotarget.18782. eCollection 2017 Sep 22.
|
| 251 |
Factors influencing serum chemerin and kallistatin concentrations in patients with alcohol-induced liver cirrhosis.Ann Agric Environ Med. 2019 Mar 22;26(1):143-147. doi: 10.26444/aaem/100536. Epub 2019 Jan 3.
|
| 252 |
Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection.J Viral Hepat. 2019 Feb;26(2):258-262. doi: 10.1111/jvh.13027. Epub 2018 Nov 14.
|
| 253 |
Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases.Biomed Res Int. 2019 May 22;2019:9321494. doi: 10.1155/2019/9321494. eCollection 2019.
|
| 254 |
Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C.Expert Opin Drug Metab Toxicol. 2018 Jun;14(6):649-657. doi: 10.1080/17425255.2018.1483336. Epub 2018 Jun 10.
|
| 255 |
Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5.Acta Paediatr. 2010 Oct;99(10):1592-4. doi: 10.1111/j.1651-2227.2010.01869.x.
|
| 256 |
MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis.Arch Toxicol. 2018 Sep;92(9):2935-2946. doi: 10.1007/s00204-018-2278-9. Epub 2018 Aug 10.
|
| 257 |
Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.Mol Genet Genomic Med. 2019 Jul;7(7):e00716. doi: 10.1002/mgg3.716. Epub 2019 May 23.
|
| 258 |
Involvement of the serine/threonine p70S6 kinase in TGF-beta1-induced ADAM12 expression in cultured human hepatic stellate cells.J Hepatol. 2005 Dec;43(6):1038-44. doi: 10.1016/j.jhep.2005.05.025. Epub 2005 Jun 29.
|
| 259 |
A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.Gut. 2014 May;63(5):832-43. doi: 10.1136/gutjnl-2012-304037. Epub 2013 Jun 13.
|
| 260 |
Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.Am J Cancer Res. 2017 Mar 1;7(3):433-447. eCollection 2017.
|
| 261 |
Afamin and adropin in patients with alcohol-induced liver cirrhosis.Ann Agric Environ Med. 2018 Sep 25;25(3):527-531. doi: 10.26444/aaem/92650. Epub 2018 Jul 25.
|
| 262 |
AGA Clinical Practice Update: Coagulation in Cirrhosis.Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12.
|
| 263 |
Diagnostic algorithm for determining primary tumor sites using peritoneal fluid.PLoS One. 2018 Jul 19;13(7):e0199715. doi: 10.1371/journal.pone.0199715. eCollection 2018.
|
| 264 |
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease.Mol Syst Biol. 2019 Mar 1;15(3):e8793. doi: 10.15252/msb.20188793.
|
| 265 |
Noninvasive characterization of graft steatosis after liver transplantation.Scand J Gastroenterol. 2015 Feb;50(2):224-32. doi: 10.3109/00365521.2014.983156. Epub 2014 Nov 27.
|
| 266 |
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nat Genet. 2013 Aug;45(8):951-6. doi: 10.1038/ng.2681. Epub 2013 Jun 23.
|
| 267 |
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.Gut. 2017 Jan;66(1):145-155. doi: 10.1136/gutjnl-2015-309600. Epub 2015 Sep 17.
|
| 268 |
Effects of beta-hydroxy-beta-methylbutyrate supplementation on skeletal muscle in healthy and cirrhotic rats.Int J Exp Pathol. 2019 Jun;100(3):175-183. doi: 10.1111/iep.12322. Epub 2019 Jul 18.
|
| 269 |
Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice.J Pharmacol Exp Ther. 2012 May;341(2):307-16. doi: 10.1124/jpet.111.189340. Epub 2012 Jan 23.
|
| 270 |
Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis.Dig Liver Dis. 2017 Jan;49(1):70-76. doi: 10.1016/j.dld.2016.10.017. Epub 2016 Nov 4.
|
| 271 |
Liver transplantation for progressive familial intrahepatic cholestasis: clinical and histopathological findings, outcome and impact on growth.Pediatr Transplant. 2007 Sep;11(6):634-40. doi: 10.1111/j.1399-3046.2007.00722.x.
|
| 272 |
ADC similarity predicts microvascular invasion of bifocal hepatocellular carcinoma.Abdom Radiol (NY). 2018 Sep;43(9):2295-2302. doi: 10.1007/s00261-018-1469-4.
|
| 273 |
Significance of Heparin-Binding Protein and D-dimers in the Early Diagnosis of Spontaneous Bacterial Peritonitis.Mediators Inflamm. 2018 Sep 30;2018:1969108. doi: 10.1155/2018/1969108. eCollection 2018.
|
| 274 |
BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.Oncotarget. 2015 Aug 21;6(24):20252-65. doi: 10.18632/oncotarget.3857.
|
| 275 |
Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy.Rev Esp Enferm Dig. 2017 Jan;109(1):17-25. doi: 10.17235/reed.2016.4235/2016.
|
| 276 |
Increased Healthcare-Associated Infections in a Surgical Intensive Care Unit Related to Boarding Non-Surgical Patients.Surg Infect (Larchmt). 2019 May/Jun;20(4):332-337. doi: 10.1089/sur.2018.240. Epub 2019 Feb 15.
|
| 277 |
Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin.Aliment Pharmacol Ther. 2017 Jun;45(11):1427-1432. doi: 10.1111/apt.14059. Epub 2017 Apr 6.
|
| 278 |
A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosis.Dig Liver Dis. 2016 Jan;48(1):62-8. doi: 10.1016/j.dld.2015.09.011. Epub 2015 Sep 28.
|
| 279 |
Increases in endothelial caveolin-1 and cavins correlate with cirrhosis progression.Micron. 2015 Sep;76:52-61. doi: 10.1016/j.micron.2015.03.009. Epub 2015 Mar 31.
|
| 280 |
Prognostic and Diagnostic Significance of SDPR-Cavin-2 in Hepatocellular Carcinoma.Cell Physiol Biochem. 2016;39(3):950-60. doi: 10.1159/000447803. Epub 2016 Aug 12.
|
| 281 |
CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis.Cell Death Dis. 2019 Oct 22;10(11):796. doi: 10.1038/s41419-019-1966-6.
|
| 282 |
Whole genome expression profiling and screening for differentially expressed cytokine genes in human bone marrow endothelial cells treated with humoral inhibitors in liver cirrhosis.Int J Mol Med. 2013 Nov;32(5):1204-14. doi: 10.3892/ijmm.2013.1495. Epub 2013 Sep 13.
|
| 283 |
Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model.PLoS One. 2019 Jan 23;14(1):e0210588. doi: 10.1371/journal.pone.0210588. eCollection 2019.
|
| 284 |
Potential circulating biomarkers of circulating chemokines CCL5, MIP-1 and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection.BMC Infect Dis. 2019 Jun 14;19(1):523. doi: 10.1186/s12879-019-4130-0.
|
| 285 |
Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis.Cell Res. 2003 Oct;13(5):319-33. doi: 10.1038/sj.cr.7290177.
|
| 286 |
Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography.Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3294-8. doi: 10.1073/pnas.051604498.
|
| 287 |
Association of genetic polymorphisms in CD8+ T cell inhibitory genes and susceptibility to and progression of chronic HBV infection.Infect Genet Evol. 2015 Dec;36:467-474. doi: 10.1016/j.meegid.2015.08.018. Epub 2015 Aug 18.
|
| 288 |
AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease.J Leukoc Biol. 2015 Aug;98(2):173-84. doi: 10.1189/jlb.3RU0215-074R. Epub 2015 Jun 5.
|
| 289 |
Dysfunctional neutrophil effector organelle mobilization and microbicidal protein release in alcohol-related cirrhosis.Am J Physiol Gastrointest Liver Physiol. 2017 Sep 1;313(3):G203-G211. doi: 10.1152/ajpgi.00112.2016. Epub 2017 Jun 22.
|
| 290 |
Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesis.Cancer Biomark. 2018;22(3):503-509. doi: 10.3233/CBM-171156.
|
| 291 |
Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.Tohoku J Exp Med. 2014 Mar;232(3):187-94. doi: 10.1620/tjem.232.187.
|
| 292 |
Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma.Exp Ther Med. 2019 May;17(5):4073-4079. doi: 10.3892/etm.2019.7455. Epub 2019 Mar 29.
|
| 293 |
Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography.Eur J Gastroenterol Hepatol. 2019 Mar;31(3):357-362. doi: 10.1097/MEG.0000000000001291.
|
| 294 |
Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.Liver Int. 2010 Jan;30(1):119-25. doi: 10.1111/j.1478-3231.2009.02106.x. Epub 2009 Oct 21.
|
| 295 |
Hyporesponsiveness to PegIFN2B plus ribavirin in patients with hepatitis C-related advanced fibrosis.J Hepatol. 2012 Feb;56(2):341-7. doi: 10.1016/j.jhep.2011.05.022. Epub 2011 Jul 12.
|
| 296 |
Epigenetic Effects of an Adenosine Derivative in a Wistar Rat Model of Liver Cirrhosis.J Cell Biochem. 2018 Jan;119(1):401-413. doi: 10.1002/jcb.26192. Epub 2017 Jul 4.
|
| 297 |
Genetic association between functional haplotype of collagen type III alpha 1 and chronic hepatitis B and cirrhosis in Koreans.Tissue Antigens. 2008 Dec;72(6):539-48. doi: 10.1111/j.1399-0039.2008.01144.x. Epub 2008 Oct 18.
|
| 298 |
Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.Gastroenterology. 2007 Oct;133(4):1316-26. doi: 10.1053/j.gastro.2007.07.020. Epub 2007 Jul 25.
|
| 299 |
Use of Transthoracic Transdiaphragmatic Approach Assisted with Radiofrequency Ablation for Thoracoscopic Hepatectomy of Hepatic Tumor Located in Segment VIII.J Gastrointest Surg. 2019 Aug;23(8):1547-1548. doi: 10.1007/s11605-019-04172-6. Epub 2019 May 31.
|
| 300 |
Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.Gastroenterology. 2006 May;130(6):1679-87. doi: 10.1053/j.gastro.2006.02.032. Epub 2006 Mar 6.
|
| 301 |
Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells.Cancer Chemother Pharmacol. 2012 May;69(5):1173-80. doi: 10.1007/s00280-011-1810-x. Epub 2012 Jan 12.
|
| 302 |
CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma.Onco Targets Ther. 2019 Sep 23;12:7823-7831. doi: 10.2147/OTT.S219429. eCollection 2019.
|
| 303 |
Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis.Hepatology. 2004 Feb;39(2):492-9. doi: 10.1002/hep.20038.
|
| 304 |
Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis.Life Sci. 2018 Aug 15;207:50-60. doi: 10.1016/j.lfs.2018.05.048. Epub 2018 May 28.
|
| 305 |
Validation of non-invasive haemodynamic methods in patients with liver disease: the Finometer and the Task Force Monitor.Clin Physiol Funct Imaging. 2018 May;38(3):384-389. doi: 10.1111/cpf.12425. Epub 2017 Apr 12.
|
| 306 |
Expression of c-myc promoter binding protein (MBP-1), a novel eukaryotic repressor gene, in cirrhosis and human hepatocellular carcinoma.Dig Dis Sci. 2001 Mar;46(3):563-6. doi: 10.1023/a:1005651216212.
|
| 307 |
Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations.Clin Gastroenterol Hepatol. 2019 Jul;17(8):1607-1615.e2. doi: 10.1016/j.cgh.2018.10.045. Epub 2018 Nov 1.
|
| 308 |
Hepato-cerebral syndrome: genetic and pathological studies in an infant with a dGK mutation.Acta Neuropathol. 2004 Aug;108(2):168-71. doi: 10.1007/s00401-004-0872-9. Epub 2004 May 19.
|
| 309 |
Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.Clin Rev Allergy Immunol. 2020 Oct;59(2):175-194. doi: 10.1007/s12016-019-08772-7.
|
| 310 |
Expression of deleted in malignant brain tumours 1 (DMBT1) relates to the proliferation and malignant transformation of hepatic progenitor cells in hepatitis B virus-related liver diseases.Histopathology. 2012 Jan;60(2):249-60. doi: 10.1111/j.1365-2559.2011.04082.x.
|
| 311 |
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.Cancer Lett. 2010 Mar 1;289(1):32-9. doi: 10.1016/j.canlet.2009.07.016. Epub 2009 Aug 15.
|
| 312 |
Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease.PLoS One. 2013 Jul 19;8(7):e65982. doi: 10.1371/journal.pone.0065982. Print 2013.
|
| 313 |
Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking.Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):1129-1137. doi: 10.1016/j.bbadis.2018.01.019. Epub 2018 Jan 31.
|
| 314 |
Autoimmune hepatitis.J Hepatol. 2000;32(1 Suppl):181-97. doi: 10.1016/s0168-8278(00)80425-0.
|
| 315 |
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.Amino Acids. 2011 Mar;40(3):1003-13. doi: 10.1007/s00726-010-0729-6. Epub 2010 Sep 7.
|
| 316 |
The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort.Int J Cancer. 2017 Sep 15;141(6):1148-1160. doi: 10.1002/ijc.30818. Epub 2017 Jun 21.
|
| 317 |
Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.Hepatology. 2017 Oct;66(4):1219-1231. doi: 10.1002/hep.29267. Epub 2017 Aug 26.
|
| 318 |
High expression of FAM13A was associated with increasing the liver cirrhosis risk.Mol Genet Genomic Med. 2019 Mar;7(3):e543. doi: 10.1002/mgg3.543. Epub 2019 Jan 2.
|
| 319 |
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).Clin Infect Dis. 2020 Mar 3;70(6):1153-1160. doi: 10.1093/cid/ciz304.
|
| 320 |
Prognostic value of lectin pathway molecules and complement proteins in ascitic fluid and blood in patients with liver cirrhosis.Scand J Gastroenterol. 2018 Jan;53(1):64-69. doi: 10.1080/00365521.2017.1386710. Epub 2017 Oct 6.
|
| 321 |
Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.Liver Int. 2017 Jul;37(7):1023-1031. doi: 10.1111/liv.13368. Epub 2017 Feb 28.
|
| 322 |
Genome-wide association study of chronic hepatitis B virus infection reveals a novel candidate risk allele on 11q22.3.J Med Genet. 2013 Nov;50(11):725-32. doi: 10.1136/jmedgenet-2013-101724. Epub 2013 Sep 24.
|
| 323 |
Angiogenic factor expression in hepatic cirrhosis.Mediators Inflamm. 2007;2007:67187. doi: 10.1155/2007/67187. Epub 2007 Feb 28.
|
| 324 |
Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.Gastroenterology. 2012 Mar;142(3):612-621.e5. doi: 10.1053/j.gastro.2011.11.029. Epub 2011 Dec 1.
|
| 325 |
'Durate variant with clinical signs' has alpha1 -antitrypsin genotype ZZ.J Med Genet. 1976 Feb;13(1):46-8. doi: 10.1136/jmg.13.1.46.
|
| 326 |
Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population.Int J Endocrinol. 2019 Jan 13;2019:9120467. doi: 10.1155/2019/9120467. eCollection 2019.
|
| 327 |
Advance care planning (ACP) for specialists managing cirrhosis: A focus on patient-centered care.Hepatology. 2018 May;67(5):2025-2040. doi: 10.1002/hep.29731. Epub 2018 Apr 6.
|
| 328 |
GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis.BMC Cancer. 2014 Apr 9;14:248. doi: 10.1186/1471-2407-14-248.
|
| 329 |
Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?.Liver Int. 2017 Oct;37(10):1461-1467. doi: 10.1111/liv.13393. Epub 2017 Mar 23.
|
| 330 |
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.Gastroenterology. 2012 Nov;143(5):1244-1252.e12. doi: 10.1053/j.gastro.2012.07.097. Epub 2012 Jul 27.
|
| 331 |
Association of the G-protein and 2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial.Gut. 2010 Nov;59(11):1545-53. doi: 10.1136/gut.2010.210732. Epub 2010 Sep 9.
|
| 332 |
Magnetic Nanoparticle-Based Automatic Chemiluminescent Enzyme Immunoassay for Golgi Protein 73 and the Clinical Assessment.J Nanosci Nanotechnol. 2019 Apr 1;19(4):1971-1977. doi: 10.1166/jnn.2019.16485.
|
| 333 |
Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma.Int J Cancer. 2006 Sep 15;119(6):1330-7. doi: 10.1002/ijc.22005.
|
| 334 |
Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection.Clin Gastroenterol Hepatol. 2019 Dec;17(13):2808-2810.e2. doi: 10.1016/j.cgh.2019.01.002. Epub 2019 Jan 11.
|
| 335 |
eRF3b-37 inhibits the TGF-1-induced activation of hepatic stellate cells by regulating cell proliferation, G0/G1 arrest, apoptosis and migration.Int J Mol Med. 2018 Dec;42(6):3602-3612. doi: 10.3892/ijmm.2018.3900. Epub 2018 Sep 26.
|
| 336 |
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.Hepatology. 2009 Mar;49(3):775-80. doi: 10.1002/hep.22707.
|
| 337 |
Circulating miR-21, miR-210 and miR-146a as potential biomarkers to differentiate acute tubular necrosis from hepatorenal syndrome in patients with liver cirrhosis: a pilot study.Clin Chem Lab Med. 2018 Apr 25;56(5):739-747. doi: 10.1515/cclm-2017-0483.
|
| 338 |
Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.Oncol Rep. 2014 May;31(5):2328-34. doi: 10.3892/or.2014.3111. Epub 2014 Mar 24.
|
| 339 |
ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency.PLoS One. 2017 Jun 15;12(6):e0179369. doi: 10.1371/journal.pone.0179369. eCollection 2017.
|
| 340 |
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.Liver Int. 2007 Sep;27(7):997-1007. doi: 10.1111/j.1478-3231.2007.01544.x.
|
| 341 |
Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease.Tissue Antigens. 2003 Feb;61(2):159-65. doi: 10.1034/j.1399-0039.2003.00015.x.
|
| 342 |
High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma.Cancer Manag Res. 2018 Nov 20;10:5979-5989. doi: 10.2147/CMAR.S181742. eCollection 2018.
|
| 343 |
Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy.Antivir Ther. 2017;22(1):61-70. doi: 10.3851/IMP3085. Epub 2016 Sep 15.
|
| 344 |
Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma.Int J Med Sci. 2015 Feb 15;12(3):256-63. doi: 10.7150/ijms.10735. eCollection 2015.
|
| 345 |
Serine Protease HtrA2/Omi Deficiency Impairs Mitochondrial Homeostasis and Promotes Hepatic Fibrogenesis via Activation of Hepatic Stellate Cells.Cells. 2019 Sep 20;8(10):1119. doi: 10.3390/cells8101119.
|
| 346 |
Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma.Medicine (Baltimore). 2019 Jan;98(2):e13996. doi: 10.1097/MD.0000000000013996.
|
| 347 |
IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis.Front Med (Lausanne). 2019 Sep 4;6:179. doi: 10.3389/fmed.2019.00179. eCollection 2019.
|
| 348 |
Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection.Genes Immun. 2005 May;6(3):242-7. doi: 10.1038/sj.gene.6364168.
|
| 349 |
Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients.Liver Int. 2008 Jul;28(6):798-806. doi: 10.1111/j.1478-3231.2008.01725.x.
|
| 350 |
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.Antivir Ther. 2017;22(7):551-558. doi: 10.3851/IMP3134. Epub 2017 Feb 6.
|
| 351 |
JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation.Hepatology. 2006 Dec;44(6):1432-40. doi: 10.1002/hep.21436.
|
| 352 |
The Clinical Features of Patients with Chronic Hepatitis C Virus Infections Are Associated with Killer Cell Immunoglobulin-Like Receptor Genes and Their Expression on the Surface of Natural Killer Cells.Front Immunol. 2018 Jan 5;8:1912. doi: 10.3389/fimmu.2017.01912. eCollection 2017.
|
| 353 |
Krppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency.Orphanet J Rare Dis. 2012 May 23;7:29. doi: 10.1186/1750-1172-7-29.
|
| 354 |
Pre-Hepatectomy Assessment of Bile Transporter Expression by Gadoxetic Acid-Enhanced MRI in a Rat Model of Liver Cirrhosis.J Invest Surg. 2017 Aug;30(4):265-271. doi: 10.1080/08941939.2016.1238983. Epub 2016 Oct 26.
|
| 355 |
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.Genes Chromosomes Cancer. 2009 Dec;48(12):1057-68. doi: 10.1002/gcc.20708.
|
| 356 |
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.J Infect Dis. 2020 Feb 3;221(4):589-597. doi: 10.1093/infdis/jiz496.
|
| 357 |
Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis.Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1093-106. doi: 10.1152/ajpgi.00292.2009. Epub 2009 Oct 8.
|
| 358 |
High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma.J Transl Med. 2013 Feb 15;11:41. doi: 10.1186/1479-5876-11-41.
|
| 359 |
DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.Cancer Res. 2016 Feb 1;76(3):594-606. doi: 10.1158/0008-5472.CAN-15-1336. Epub 2016 Jan 15.
|
| 360 |
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.Am J Pathol. 2001 Sep;159(3):945-53. doi: 10.1016/S0002-9440(10)61770-1.
|
| 361 |
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients WithGenotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.Gastroenterology. 2016 Nov;151(5):893-901.e1. doi: 10.1053/j.gastro.2016.07.039. Epub 2016 Jul 30.
|
| 362 |
Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.Am J Gastroenterol. 2019 Oct;114(10):1574-1586. doi: 10.14309/ajg.0000000000000340.
|
| 363 |
Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis.PLoS One. 2017 Oct 11;12(10):e0185997. doi: 10.1371/journal.pone.0185997. eCollection 2017.
|
| 364 |
Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma.Pathol Oncol Res. 2008 Mar;14(1):15-22. doi: 10.1007/s12253-008-9005-4. Epub 2008 Apr 2.
|
| 365 |
Up-regulation of RIP1 and IPS-1 in chronic HBV infected patients.Genet Mol Biol. 2019 Apr-Jun;42(2):337-343. doi: 10.1590/1678-4685-GMB-2018-0071. Epub 2019 Aug 19.
|
| 366 |
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.Am J Gastroenterol. 2018 Oct;113(10):1475-1483. doi: 10.1038/s41395-018-0041-8. Epub 2018 Mar 13.
|
| 367 |
The putative tumor suppressor gene on chromosome 5q for hepatocellular carcinoma is distinct from the MCC and APC genes.Cancer Detect Prev. 1993;17(3):405-9.
|
| 368 |
Epidemiology of hepatic encephalopathy in german hospitals - the EpHE study.Z Gastroenterol. 2017 Aug;55(8):741-747. doi: 10.1055/s-0043-114671. Epub 2017 Jul 12.
|
| 369 |
Salvianolic Acid B Inhibits Activation of Human Primary Hepatic Stellate Cells Through Downregulation of the Myocyte Enhancer Factor 2 Signaling Pathway.Front Pharmacol. 2019 Apr 11;10:322. doi: 10.3389/fphar.2019.00322. eCollection 2019.
|
| 370 |
A correlation between gastrointestinal dysfunction and cirrhosis severity.Medicine (Baltimore). 2018 Sep;97(37):e12070. doi: 10.1097/MD.0000000000012070.
|
| 371 |
Vitronectins produced by human cirrhotic liver and CCl(4)-treated rats differ in their glycosylation pattern and tissue remodeling activity.FEBS Open Bio. 2019 Mar 18;9(4):755-768. doi: 10.1002/2211-5463.12616. eCollection 2019 Apr.
|
| 372 |
Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice.Hum Mol Genet. 2009 Jan 1;18(1):12-26. doi: 10.1093/hmg/ddn309. Epub 2008 Sep 24.
|
| 373 |
PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.J Hepatol. 2020 Mar;72(3):506-518. doi: 10.1016/j.jhep.2019.09.033. Epub 2019 Dec 6.
|
| 374 |
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.JCI Insight. 2019 Dec 19;4(24):e133410. doi: 10.1172/jci.insight.133410.
|
| 375 |
Genetic predisposition to organ-specific endpoints of alcoholism.Alcohol Clin Exp Res. 1996 Dec;20(9):1528-33. doi: 10.1111/j.1530-0277.1996.tb01695.x.
|
| 376 |
Pro-Brain Natriuretic Peptide and Troponin T-Hypersensitivity Levels Correlate With the Severity of Liver Dysfunction in Liver Cirrhosis.Am J Med Sci. 2017 Aug;354(2):131-139. doi: 10.1016/j.amjms.2017.04.005. Epub 2017 Apr 7.
|
| 377 |
Effect of Different Circuit Training on Cardiovascular Responses in Cirrhotic Patients.Int J Sports Med. 2019 Feb;40(2):139-146. doi: 10.1055/a-0783-2747. Epub 2018 Dec 17.
|
| 378 |
Molecular genetic aspects of alcohol metabolism and alcoholism.Pharmacopsychiatry. 1997 May;30(3):79-84. doi: 10.1055/s-2007-979487.
|
| 379 |
Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis.Gastroenterology. 2007 Jun;132(7):2533-41. doi: 10.1053/j.gastro.2006.12.035. Epub 2006 Dec 20.
|
| 380 |
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.PLoS One. 2015 Jul 29;10(7):e0129743. doi: 10.1371/journal.pone.0129743. eCollection 2015.
|
| 381 |
Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial.Biol Trace Elem Res. 2020 May;195(1):71-81. doi: 10.1007/s12011-019-01851-y. Epub 2019 Aug 7.
|
| 382 |
Characterization of Niemann-Pick Type C2 protein expression in multiple cancers using a novel NPC2 monoclonal antibody.PLoS One. 2013 Oct 17;8(10):e77586. doi: 10.1371/journal.pone.0077586. eCollection 2013.
|
| 383 |
Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites. Am J Physiol Renal Physiol. 2005 May;288(5):F1044-52. doi: 10.1152/ajprenal.00142.2004. Epub 2004 Dec 21.
|
| 384 |
Treatment of nave patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA.PLoS One. 2014 Oct 10;9(10):e108751. doi: 10.1371/journal.pone.0108751. eCollection 2014.
|
| 385 |
Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.Biochem J. 2004 Sep 1;382(Pt 2):725-31. doi: 10.1042/BJ20040413.
|
| 386 |
The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210.Aliment Pharmacol Ther. 2017 Mar;45(5):733-743. doi: 10.1111/apt.13927. Epub 2017 Jan 13.
|
| 387 |
Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication.Liver Int. 2009 Oct;29(9):1413-21. doi: 10.1111/j.1478-3231.2009.02061.x. Epub 2009 Jun 5.
|
| 388 |
Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl--D-glucosaminidase.J Gastroenterol Hepatol. 2019 Jan;34(1):234-240. doi: 10.1111/jgh.14387. Epub 2018 Aug 21.
|
| 389 |
Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists.Clin Gastroenterol Hepatol. 2018 Dec;16(12):1964-1973.e1. doi: 10.1016/j.cgh.2018.04.033. Epub 2018 Apr 24.
|
| 390 |
Oxidored-nitro domain-containing protein 1 promotes liver fibrosis by activating the Wnt/-catenin signaling pathway invitro.Mol Med Rep. 2017 Oct;16(4):5050-5054. doi: 10.3892/mmr.2017.7165. Epub 2017 Aug 4.
|
| 391 |
Peginterferon is preferable to entecavir for prevention of unfavourable events in patients with HBeAg-positive chronic hepatitis B: A five-year observational cohort study.J Viral Hepat. 2017 Nov;24 Suppl 1:12-20. doi: 10.1111/jvh.12755.
|
| 392 |
Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation.Thromb Haemost. 2006 Feb;95(2):221-3. doi: 10.1160/TH05-08-0555.
|
| 393 |
Proteome analysis of hepatic non-parenchymal cells of immune liver fibrosis rats.Sci China Life Sci. 2014 Mar;57(3):303-314. doi: 10.1007/s11427-014-4619-0. Epub 2014 Feb 21.
|
| 394 |
Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma.Int J Oncol. 2014 Nov;45(5):2005-12. doi: 10.3892/ijo.2014.2637. Epub 2014 Sep 3.
|
| 395 |
Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G174-G188. doi: 10.1152/ajpgi.00041.2019. Epub 2019 Oct 21.
|
| 396 |
Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis.J Hepatol. 2005 Oct;43(4):687-95. doi: 10.1016/j.jhep.2005.03.024.
|
| 397 |
Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China.BMJ Open. 2019 Jan 15;9(1):e023567. doi: 10.1136/bmjopen-2018-023567.
|
| 398 |
Analysis of glycero-lysophospholipids in gastric cancerous ascites.J Lipid Res. 2017 Apr;58(4):763-771. doi: 10.1194/jlr.P072090. Epub 2017 Jan 31.
|
| 399 |
Housekeeping gene variability in the liver of alcoholic patients.Alcohol Clin Exp Res. 2012 Feb;36(2):258-66. doi: 10.1111/j.1530-0277.2011.01627.x. Epub 2011 Sep 13.
|
| 400 |
Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-B activation, in hepatocellular carcinoma.Gastroenterology. 2010 Dec;139(6):2183-2194.e5. doi: 10.1053/j.gastro.2010.06.049. Epub 2010 Jun 20.
|
| 401 |
Homeobox gene Prx1 is expressed in activated hepatic stellate cells and transactivates collagen alpha1(I) promoter.Exp Biol Med (Maywood). 2008 Mar;233(3):286-96. doi: 10.3181/0707-RM-177.
|
| 402 |
Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.Ann Hepatol. 2017 Sep-Oct;16(5):780-787. doi: 10.5604/01.3001.0010.2789.
|
| 403 |
Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.Dig Dis Sci. 2018 Mar;63(3):665-675. doi: 10.1007/s10620-017-4897-z. Epub 2018 Feb 1.
|
| 404 |
A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.PLoS One. 2016 Dec 19;11(12):e0168685. doi: 10.1371/journal.pone.0168685. eCollection 2016.
|
| 405 |
Methylation of tumour suppressor genes RUNX3, RASSF1A and E-Cadherin in HCV-related liver cirrhosis and hepatocellular carcinoma.Br J Biomed Sci. 2020 Jan;77(1):35-40. doi: 10.1080/09674845.2019.1694123. Epub 2019 Dec 2.
|
| 406 |
Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations.J Hepatol. 2004 May;40(5):774-80. doi: 10.1016/j.jhep.2004.01.008.
|
| 407 |
Diagnostic Value of Serum SMP30 and Anti-SMP30 Antibody in Hepatocellular Carcinoma.Lab Med. 2018 Jul 5;49(3):203-210. doi: 10.1093/labmed/lmy004.
|
| 408 |
Induction of MIC-1/growth differentiation factor-15 following bile duct injury.J Gastrointest Surg. 2003 Nov;7(7):901-5. doi: 10.1007/s11605-003-0037-5.
|
| 409 |
Prognostic value of increased expression of RACO-1 in patients with hepatitis B-related hepatocellular carcinoma.Ther Clin Risk Manag. 2017 Feb 15;13:191-200. doi: 10.2147/TCRM.S125331. eCollection 2017.
|
| 410 |
Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial.EBioMedicine. 2017 Sep;23:79-87. doi: 10.1016/j.ebiom.2017.08.016. Epub 2017 Aug 19.
|
| 411 |
Inverse correlation of ribosomal protein S27A and multifunctional protein YB-1 in hepatocellular carcinoma.Clin Biochem. 2014 Sep;47(13-14):1262-4. doi: 10.1016/j.clinbiochem.2014.05.004. Epub 2014 May 14.
|
| 412 |
Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.Nat Rev Nephrol. 2020 Mar;16(3):137-155. doi: 10.1038/s41581-019-0218-4. Epub 2019 Nov 13.
|
| 413 |
Relaxin receptors in hepatic stellate cells and cirrhotic liver.Biochem Pharmacol. 2007 Apr 1;73(7):1033-40. doi: 10.1016/j.bcp.2006.12.007. Epub 2006 Dec 10.
|
| 414 |
The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients.Clin Exp Nephrol. 2017 Dec;21(6):1113-1123. doi: 10.1007/s10157-017-1394-9. Epub 2017 Mar 29.
|
| 415 |
Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma.J Gastroenterol. 2008;43(5):378-89. doi: 10.1007/s00535-008-2170-0. Epub 2008 Jul 1.
|
| 416 |
Systematic quantification of histological patterns shows accuracy in reflecting cirrhotic remodeling.J Gastroenterol Hepatol. 2017 Sep;32(9):1631-1639. doi: 10.1111/jgh.13722.
|
| 417 |
Phylogenetic, virological, and clinical characteristics of genotype C hepatitis B virus with TCC at codon 15 of the precore region.J Clin Microbiol. 2006 Mar;44(3):681-7. doi: 10.1128/JCM.44.3.681-687.2006.
|
| 418 |
Hepatitis B and renal function: A matched study comparing non-hepatitis B, untreated, treated and cirrhotic hepatitis patients.Liver Int. 2019 Apr;39(4):655-666. doi: 10.1111/liv.14009. Epub 2018 Dec 18.
|
| 419 |
Constant serum levels of secreted asialoglycoprotein receptor sH2a and decrease with cirrhosis.World J Gastroenterol. 2011 Dec 28;17(48):5305-9. doi: 10.3748/wjg.v17.i48.5305.
|
| 420 |
Reduced SHARPIN and LUBAC Formation May Contribute to CCl? or Acetaminophen-Induced Liver Cirrhosis in Mice.Int J Mol Sci. 2017 Feb 4;18(2):326. doi: 10.3390/ijms18020326.
|
| 421 |
Increased Siglec-1 expression in monocytes of patients with primary biliary cirrhosis.Immunol Invest. 2010;39(6):645-60. doi: 10.3109/08820139.2010.485625.
|
| 422 |
Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.Oncotarget. 2015 Aug 21;6(24):20327-44. doi: 10.18632/oncotarget.3972.
|
| 423 |
Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma.Clin Chim Acta. 2019 May;492:37-44. doi: 10.1016/j.cca.2019.02.001. Epub 2019 Feb 2.
|
| 424 |
Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany.PLoS One. 2019 Apr 4;14(4):e0214795. doi: 10.1371/journal.pone.0214795. eCollection 2019.
|
| 425 |
Overexpression of Smad ubiquitin regulatory factor 2 suppresses transforming growth factor- mediated liver fibrosis.J Dig Dis. 2012 Jun;13(6):327-34. doi: 10.1111/j.1751-2980.2012.00592.x.
|
| 426 |
Methylation of SOX1 and VIM promoters in serum as potential biomarkers for hepatocellular carcinoma.Neoplasma. 2017;64(5):745-753. doi: 10.4149/neo_2017_513.
|
| 427 |
Viral load speaks little about toll on liver.Hepatobiliary Pancreat Dis Int. 2007 Oct;6(5):483-6.
|
| 428 |
Degradation of splicing factor SRSF3 contributes to progressive liver disease.J Clin Invest. 2019 Aug 8;129(10):4477-4491. doi: 10.1172/JCI127374.
|
| 429 |
Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.J Hepatol. 2005 Jun;42(6):860-9. doi: 10.1016/j.jhep.2005.01.027. Epub 2005 Apr 11.
|
| 430 |
SULF1/SULF2 reactivation during liver damage and tumour growth.Histochem Cell Biol. 2016 Jul;146(1):85-97. doi: 10.1007/s00418-016-1425-8. Epub 2016 Mar 25.
|
| 431 |
MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis.Oncotarget. 2017 Dec 15;9(1):1075-1090. doi: 10.18632/oncotarget.23262. eCollection 2018 Jan 2.
|
| 432 |
Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population.Viral Immunol. 2012 Feb;25(1):73-8. doi: 10.1089/vim.2011.0053. Epub 2012 Jan 6.
|
| 433 |
Risk factors of hepatitis C virus-related liver cirrhosis in young adults: positive family history of liver disease and transporter associated with antigen processing 2(TAP2)*0201 Allele.J Med Virol. 2001 Jun;64(2):109-16. doi: 10.1002/jmv.1025.
|
| 434 |
Long noncoding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRTPCR and metaanalysis of 393 cases.Int J Oncol. 2017 Dec;51(6):1705-1721. doi: 10.3892/ijo.2017.4164. Epub 2017 Oct 16.
|
| 435 |
Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinoma.Gene. 2019 May 15;696:219-224. doi: 10.1016/j.gene.2019.02.049. Epub 2019 Feb 22.
|
| 436 |
Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis.Ther Clin Risk Manag. 2017 Jun 22;13:733-738. doi: 10.2147/TCRM.S133983. eCollection 2017.
|
| 437 |
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.Gastroenterology. 2016 May;150(5):1219-1230.e6. doi: 10.1053/j.gastro.2016.01.032. Epub 2016 Feb 2.
|
| 438 |
Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.BMC Cancer. 2006 Apr 10;6:89. doi: 10.1186/1471-2407-6-89.
|
| 439 |
MuRF-1 and p-GSK3 expression in muscle atrophy of cirrhosis.Liver Int. 2013 May;33(5):714-21. doi: 10.1111/liv.12128. Epub 2013 Feb 24.
|
| 440 |
Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations.J Inherit Metab Dis. 2011 Feb;34(1):197-201. doi: 10.1007/s10545-010-9250-z. Epub 2010 Dec 10.
|
| 441 |
The association between adiponectin (+45T/G) and adiponectin receptor-2 (+795G/A) single nucleotide polymorphisms with cirrhosis in Iranian population.Mol Biol Rep. 2012 Mar;39(3):3219-23. doi: 10.1007/s11033-011-1089-3. Epub 2011 Jun 25.
|
| 442 |
Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.Hepatology. 2014 Dec;60(6):1972-82. doi: 10.1002/hep.27198. Epub 2014 Sep 22.
|
| 443 |
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.Hepatology. 1997 Jan;25(1):211-5. doi: 10.1053/jhep.1997.v25.pm0008985292.
|
| 444 |
Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis.Lancet Oncol. 2017 Feb;18(2):e101-e112. doi: 10.1016/S1470-2045(16)30569-1.
|
| 445 |
Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease.Clin Res Hepatol Gastroenterol. 2019 Aug;43(4):410-416. doi: 10.1016/j.clinre.2018.11.014. Epub 2019 Apr 30.
|
| 446 |
Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.Gastroenterology. 2016 Apr;150(4):982-97.e30. doi: 10.1053/j.gastro.2015.11.038. Epub 2015 Nov 26.
|
| 447 |
ADH1B*2 allele is protective against alcoholism but not chronic liver disease in the Hungarian population.Addiction. 2010 May;105(5):891-6. doi: 10.1111/j.1360-0443.2009.02876.x. Epub 2010 Mar 2.
|
| 448 |
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection.Hepatology. 2016 Feb;63(2):418-27. doi: 10.1002/hep.28322. Epub 2015 Dec 18.
|
| 449 |
The association between PIN1 genetic polymorphisms and the risk of chronic hepatitis B and hepatitis B virus-related liver cirrhosis: A case-control study.Medicine (Baltimore). 2018 Aug;97(35):e12123. doi: 10.1097/MD.0000000000012123.
|
| 450 |
AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.Sci Rep. 2018 Sep 14;8(1):13802. doi: 10.1038/s41598-018-30800-3.
|
| 451 |
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.Gut. 2015 Sep;64(9):1434-43. doi: 10.1136/gutjnl-2014-308338. Epub 2014 Dec 10.
|
| 452 |
Influence of aquaporin-1 gene polymorphism on water retention in liver cirrhosis.Scand J Gastroenterol. 2011 Oct;46(10):1267-74. doi: 10.3109/00365521.2011.603161. Epub 2011 Jul 27.
|
| 453 |
Altered regulation of Prox1-gene-expression in liver tumors.BMC Cancer. 2008 Apr 9;8:92. doi: 10.1186/1471-2407-8-92.
|
| 454 |
Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.Virol J. 2014 Jun 20;11:117. doi: 10.1186/1743-422X-11-117.
|
| 455 |
MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis.PLoS One. 2014 Oct 10;9(10):e108005. doi: 10.1371/journal.pone.0108005. eCollection 2014.
|
| 456 |
Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease.J Pediatr. 2006 Nov;149(5):713-7. doi: 10.1016/j.jpeds.2006.08.016.
|
| 457 |
Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.Hum Mol Genet. 2014 Jul 15;23(14):3883-90. doi: 10.1093/hmg/ddu076. Epub 2014 Feb 20.
|
| 458 |
Tumor necrosis factor--induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.Virol J. 2019 Oct 28;16(1):120. doi: 10.1186/s12985-019-1224-7.
|
|
|
|
|
|
|
